MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Neogene Therapeutics
Attachments
Neogene Therapeutics – Pushing the frontier by pioneering a new class of fully personalized T cell therapies to treat cancer
Parents
Architects: Biotechnology_Genetics, Gene & Cell Therapy Companies
Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Vaccines
Companies: Acquired_(M&A)
Finance & Acquisition: AstraZeneca
Industry: Netherlands
Children
2020: Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy
2022: AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
Amsterdam, Netherlands
Neogene CEO Carsten Linnemann (2020)
Neogene Co-founder Ton Schumacher
The funding came from Vida Ventures, TPG Capital and Two River Group, co-led by EcoR1 Capital, Jeito Capital and Syncona. Polaris Partners and Pontifax
Jumps
Alaunos Therapeutics, Inc. (NASDAQ: TCRT), formerly, Ziopharm